The accreditation was expanded to include contaminants testing as well as BI’s plant-species identification method for powders and extracts, branded Identilok.
Photo © iStockphoto.com/humonia
BI Nutraceuticals (Rancho Dominguez, CA) has renewed its laboratory certification (ISO/IEC 17025:2017) by the American Association for Laboratory Accreditation (A2LA). The accreditation was expanded to include contaminants testing as well as BI’s plant-species identification method for powders and extracts, branded Identilok.
The Identilok testing program is described as a blend of cutting-edge detection systems and methodologies and invaluable “tried and true methods of taxonomic classification and microscopic evaluation by a trained botanist.” The program includes macroscopic taxonomy testing, microscopic image analysis, thin-layer chromatography, Fourier transform infrared spectroscopy, organleptic testing, and DNA verification.
All of BI’s ingredients undergo not only Identilok species-identification testing, but also heavy metal, pesticide, microbiology, and irradiation testing.
“The renewal of our ISO 17025 accreditation demonstrates our commitment to sustaining the quality of our laboratory operations,” said Rupa Das, BI’s vice president of global quality and compliance, in a press release. “It is important for us to uphold the confidence of our customers with regard to the accuracy of our testing and reporting, as well as product safety. The accreditation demonstrates our technical competency and the ability of our laboratory operations to consistently produce precise and accurate test data. The expanded scope, which includes contaminants and product identification, provides further assurance for our customers of meeting their regulatory requirements. Product identification included DNA, which is integral to BI’s Identilok.”
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.